In doing so, Hahn utterly misrepresented the findings of the Mayo Clinic trial of convalescent plasma treatment. AdvertisementHahn, parroting Trump and Health and Human Services Secretary Alex Azar, said the study demonstrated a 35% reduction of mortality from the transfusion of convalescent plasma. Convalescent plasma has been shown to have a promising effect on COVID-19 patients, but thus far a modest one. No randomized controlled results on convalescent plasma have been published showing that it works. FDA Commissioner Stephen Hahn stood meekly by as President Trump slandered his agency and its 17,000 staff members, by Twitter and in person.

Source: Los Angeles Times August 24, 2020 16:49 UTC